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Mølstrøm S, Larsen NH, Simonsen JA, Washington R, Bie P.
Normotensive sodium loading in normal man: regulation of renin
secretion during -receptor blockade. Am J Physiol Regul Integr
Comp Physiol 296: R436–R445, 2009. First published December 10,
2008; doi:10.1152/ajpregu.90754.2008.—Saline administration may
change renin-angiotensin-aldosterone system (RAAS) activity and
sodium excretion at constant mean arterial pressure (MAP). We
hypothesized that such responses are elicited mainly by renal sympa-
thetic nerve activity by 1-receptors (1-RSNA), and tested the
hypothesis by studying RAAS and renal excretion during slow saline
loading at constant plasma sodium concentration (Na loading; 12
mol Na kg1 min1 for 4 h). Normal subjects were studied on
low-sodium intake with and without 1-adrenergic blockade by meto-
prolol. Metoprolol per se reduced RAAS activity as expected. Na
loading decreased plasma renin concentration (PRC) by one-third,
plasma ANG II by one-half, and plasma aldosterone by two-thirds (all
P  0.05); surprisingly, these changes were found without, as well as
during, acute metoprolol administration. Concomitantly, sodium ex-
cretion increased indistinguishably with and without metoprolol
(16  2 to 71  14 mol/min; 13  2 to 55  13 mol/min,
respectively). Na loading did not increase plasma atrial natriuretic
peptide, glomerular filtration rate (GFR by 51Cr-EDTA), MAP, or
cardiac output (CO by impedance cardiography), but increased central
venous pressure (CVP) by 2.0 mmHg (P  0.05). During Na
loading, sodium excretion increased with CVP at an average slope of
7 mol min1 mmHg1. Concomitantly, plasma vasopressin de-
creased by 30–40% (P  0.05). In conclusion, 1-adrenoceptor
blockade affects neither the acute saline-mediated deactivation of
RAAS nor the associated natriuretic response, and the RAAS response
to modest saline loading seems independent of changes in MAP, CO,
GFR, 1-mediated effects of norepinephrine, and ANP. Unexpect-
edly, the results do not allow assessment of the relative importance of
RAAS-dependent and -independent regulation of renal sodium excre-
tion. The results are compatible with the notion that at constant arterial
pressure, a volume receptor elicited reduction in RSNA via receptors
other than 1-adrenoceptors, decreases renal tubular sodium reabsorp-
tion proximal to the macula densa leading to increased NaCl concen-
tration at the macula densa, and subsequent inhibition of renin
secretion.
blood pressure; angiotensin; aldosterone; natriuresis; sodium balance
THE RENIN-ANGIOTENSIN-ALDOSTERONE system (RAAS) is an es-
sential regulator of fluid balance and arterial blood pressure.
The secretion of renin is adjusted to body fluid status by
changes in renal arterial pressure, in renal sympathetic nerve
activity (RSNA), and in the composition of the fluid to which
the macula densa (MD) cells are exposed (15, 22) through a
complex interaction of a number of signaling pathways (30).
RSNA stimulates renin secretion via 1-receptors (10). How-
ever, the relative contribution of the three classical mecha-
nisms under normal conditions in man, and the possibility that
other mechanisms, e.g., hormonal systems, also contribute
significantly, remain poorly elucidated.
Years ago, experiments in conscious dogs showed that a
robust volume expansion reduces RSNA via a reflex mediated
by the vagus nerve (24). Subsequently, other experiments in
conscious dogs have shown that renin secretion is markedly
inhibited by modest salt loading, also under conditions where
blood pressure or glomerular filtration rate (GFR) did not
change (28). It was tempting to assume that the well-known
effect of volume expansion on renin secretion is mediated by
RSNA via 1-receptors (hereafter called 1-mediated renal
nerve activity). However, we have volume expanded dogs
during the administration of the adrenergic 1-receptor antag-
onist metoprolol (7a) and found that this is probably not the
case. During metoprolol administration, the relative decreases
in plasma renin, ANG II, and aldosterone caused by salt
loading were very similar to the decreases occurring without
metoprolol. Similarities between the deactivation patterns of
the RAAS were found at regular, as well as low-sodium, diets.
These results are strong evidence in favor of the notion that the
homeostatic regulation of renin secretion is independent of
renal nerve activity expressed via 1-receptors, also under
conditions where arterial blood pressure is constant.
We have previously shown in humans that marked natri-
uretic responses may be initiated by saline loading without any
changes in arterial pressure (2, 4, 27). Actually, in one of these
studies, natriuresis occurred together with a small decrease in
arterial pressure (2), clearly indicating that an increase in blood
pressure is not a necessary precondition for the natriuresis. In
the studies of humans, the natriuresis caused by sodium load-
ing consistently occurred concomitant with a decrease in
RAAS activity, and in contrast to an increase in arterial
pressure, deactivation of the RAAS seems to be a necessary
condition of the development of a natriuretic response. So far,
the human results appear congruent with the dog data.
With the present study, we wanted to elucidate whether
homeostatic regulation of renin secretion in humans also oc-
curs unimpeded when changes in blood pressure, GFR, and
1-mediated effects of norepinephrine do not contribute. We
tested the hypothesis that in man the deactivation of the RAAS
with slow saline loading at constant blood pressure and GFR is
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reduced by 1-adrenoceptor blockade. In the dog study (7a),
we applied hypertonic saline to minimize the volume element
of the perturbation. The present investigation was designed to
avoid any increase in the plasma sodium concentration, and
central venous pressure was measured to ascertain the volume
effect. Based on the expectation that RAAS activity in man is
a log-linear function of sodium intake (cf. Ref. 19), the inves-
tigations were conducted after several days of low-salt diet to
increase the control values of RAAS activity.
METHODS
Subjects
Experiments were carried out in eight healthy male volunteers aged
23–28 yr, weighing 75 to 91 kg (81.4  2.3 kg; mean  SE) with a
body mass index of 22.1 to 26.3 kg/m2 (23.6 0.5 kg/m2; mean
SE). All subjects gave written informed consent. The study was
approved by the local ethics committee (file no. VF 20050155) and
was performed in compliance with the Declaration of Helsinki. Prior
to the study, a clinical examination was performed in each subject.
None of the subjects provided any history or showed any signs of
renal disease, arrhythmia, diabetes, or hypertension, and none was
using any kind of medication for 2 wk prior to or during the study. All
subjects were normotensive and had normal plasma creatinine con-
centrations (62–134 mol/l).
Experimental Protocols
Each subject was investigated four times, and the study days were
at least 14 days apart. The subject consumed a standardized diet
containing 30 mmol NaCl/day for 4 days prior to the investigation,
i.e., the time normally required to obtain a new steady state (18). The
diet was prepared by the kitchen for special diets of the university
hospital in collaboration with a clinical dietician. The volunteers were
allowed to drink water and tea as desired. They agreed not to exercise
on the day before the experiment. To assess compliance with the
prescribed diet, 24-h urinary sodium excretion (07:00–07:00 h) was
measured on the day prior to investigation.
Before the experiment, the subject was awakened at 06:30 h. At
06:45 h he consumed a light, standardized, low-salt breakfast. At
07:00 h urine was collected, and at 07:10 h the subject was transported
to the laboratory. He was weighed, placed in a sitting position (back
at60 degrees) in an armchair for the duration of the experiment, and
allowed to stand up only for micturition. He was given 200 ml of
glucose solution (10%) and 50 ml water per os every 60 min
throughout the experiment to maintain the standardized degree of
hydration, to generate a uniform diuresis facilitating the clearance
measurements, and to suppress the feeling of hunger otherwise oc-
curring during the experiment.
GFR was measured by the clearance of 51Cr-EDTA (code CJ13PD;
Amersham Healthcare, Denmark). Before 08.15 h, a bolus injection of
51Cr-EDTA (0.0278 MBq/kg) in 5% glucose solution was given
immediately followed by a constant infusion of 51Cr-EDTA (1 MBq/
h). Plasma activity was 500 cpm/ml.
A catheter (0.8/18 gauge  700 mm; B. Braun, Cavafix Certo) was
inserted into the cubital vein preferably on the left side and advanced
to a position estimated to be the superior vena cava. Intrathoracic
placement of the tip of the catheter was confirmed by typical pressure
waveforms and characteristic responses to respiratory maneuvers. The
catheter was kept patent by infusion of heparinized saline (5 IU/ml at
7 ml/h). The transducer was positioned and zeroed at the level of the
right atrium (IC4) and connected to a monitor (model Dialogue 2000;
Danica Electronics, Rodovre, Denmark). Short catheters were inserted
into a vein on each forearm, one catheter for infusion and the other for
blood sampling.
Cardiac output (CO) and systemic vascular resistance were mea-
sured noninvasively by an impedance cardiograph (PhysioFlow PF-
03; Manatec Biomedical, Macheren, France). The mean difference
between the CO values obtained in normal subjects at rest by the
direct Fick and PhysioFlow methods has been found to be negligible
(0.07 l/min) (9).
Each experiment lasted for 7 h divided into instrumentation and
equilibration (120 min), control (60 min), four infusion periods (240
min), and postinfusion (60 min) (Fig. 1). Arterial pressures, heart rate,
and CO were determined at 15-min intervals. Central venous pressure
data was obtained every minute and averaged over 60-min periods.
MAP and heart rate were measured by an automatic blood pressure
monitor (model BP8800; Colin Europe, Courbevoie, France).
The study included four experimental protocols during the low-salt
regimen, time-control experiments (Con), metoprolol control experi-
ments (MetCon), salt-loading experiments (Salt), and salt loading
with concomitant metoprolol infusion experiments (MetSalt). In the-
ory, standard physiological saline (154 mM) elevates the concentra-
tion of sodium when infused into normal extracellular fluid. We have
previously found marginal, but significant, increases in plasma so-
dium concentration when saline was infused into subjects on a
low-salt diet providing control sodium concentrations of 135  1 or
137  1 mM (27). In the present study, physiological saline was
diluted slightly with water to obtain a sodium concentration very
similar to that of plasma. From 1 liter of normal saline, 123 ml was
removed and replaced by 123 ml of sterile water creating a sodium
concentration of 135 mM in the infusate.
Time-control series. All procedures were similar to the intervention
series (Salt and MetSalt), except that neither saline nor metoprolol
infusions occurred.
MetCon series. Forty-five minutes before the start of measure-
ments, a bolus of metoprolol (0.3 mg/kg body wt) was given, followed
Fig. 1. Time line of investigations. Recov., recovery.
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by continuous intravenous infusion (1 g kg1 min1) throughout
the experiment, which was otherwise identical to the control series.
Salt loading series. An intravenous infusion of saline was given for
240 min at a rate of 12 mol kg1 min1 corresponding to 0.09
ml kg1 min1 or 360 ml h1 70 kg1.
MetSalt loading series. The saline load was performed during
metoprolol administration as described above.
At regular intervals, 20 ml blood samples were obtained for
measurement of electrolytes, osmolality, activity of 51Cr, and hor-
mone determinations (renin, ANG II, aldosterone). In addition, atrial
natriuretic peptide (ANP) and arginine vasopressin (AVP) concentra-
tions in plasma were determined at t	 55, 235, and 355 min. The total
volume of blood sampled was  200 ml. The urinary bladder was
emptied at 09:00 h, and urine was collected hourly thereafter by
voluntary micturition. Analyses of urine samples included sodium and
potassium concentrations, osmolality, and activity of 51Cr.
The efficacy of the metoprolol protocol was investigated in five
separate experiments. The PRC response to step-up administration of
isoprenaline (2 and 4 g/min for 15 min each) was measured before
and after administration of metoprolol following the protocol de-
scribed above.
Analyses
Blood samples were centrifuged immediately at 4°C. Measure-
ments of electrolytes, osmolality, and of the activity of 51Cr were
made on the day of the experiment. Ion concentrations were measured
by flame photometry (model ILS-943; Instrumentation Laboratory,
Lexington, MA). Osmolality was determined by freezing-point de-
pression (model 3D3; Advanced Instruments, Needham Heights,
MA). The activity of 51Cr in plasma and urine samples was deter-
mined in a gamma counter.
Plasma Hormones
Plasma renin concentration. PRC was determined by the antibody
trapping method of Poulsen and Jørgensen (26) followed by a radio-
immunoassay of the ANG I formed per unit time as described
recently (20). Results are reported as milli-international units
(mIU/l) of the activity of the WHO International Standard (ref. no.
68 –356; National Institute for Biological Standards and Control,
Hertfortshire, UK) measured along with the plasma samples in
each assay. Intra- and interassay variation coefficients were 6.2 and
5.6%, respectively.
Peptide hormone concentrations in plasma were measured by
radioimmunoassay after extraction as described previously (8, 20).
The immunoreactivity of ANG II in extracts was measured using a
specific rabbit antibody (AB-5-030682). Intra- and interassay coeffi-
cients of variation were 6.6 and 9.0%, respectively. Aldosterone was
measured by a commercial kit (COAT-A-COUNT, Diagnostic Prod-
ucts, Los Angeles, CA). The detection limit was 11 pg/ml, and the
mean recovery of unlabeled aldosterone was 89%. The intra- and
interassay variation coefficients were 2.9 and 3.5%, respectively. For
AVP determinations, a specific rabbit antibody (AB3096) was used.
The detection limit of AVP was 0.15 pg/ml, and the mean recovery of
unlabeled vasopressin was 67%. The intra- and interassay variation
coefficients were 2.2 and 10.7%, respectively. Antibody against ANP
(RAS8798) was purchased from Peninsula Laboratories. The detec-
tion limit was 1.6 pg/ml, and the mean extraction recovery of unla-
beled ANP added to plasma was 71%. The intra- and interassay
variation coefficient were 3.9 and 6.5%, respectively.
Statistics
All values are presented as means  SE. Comparisons were
performed by one-way ANOVA for repeated measures. In case of
significant differences, post hoc Newman-Keuls tests were performed.
Specific comparisons between two groups were performed by subse-
quent use of Student’s paired t-test. Central venous pressure (CVP)
was measured in 1-min average, and the results characterized by
asymmetric outliers, e.g., increases associated with movements.
Therefore, the 30 data points from each sampling period were
trimmed by removal of a fixed and equal number of lowest and
highest data points. Statistical calculations were performed with
GraphPad Prism (GraphPad Software, San Diego, CA). Differences
were considered significant at P  0.05.
RESULTS
For seven subjects, the values of 24-h renal sodium output
prior to the experiments were low and similar in all series
(Con: 17  4 mmol/24 h; MetCon: 19  6 mmol/24 h; Salt:
20  6 mmol/24 h; MetSalt: 25  6 mmol/24 h), indicating
compliance with the low-salt protocol. Baseline levels of all
three RAAS variables were also uniform: PRC (Con: 59  8
mIU/l; Salt: 65  13 mIU/l), plasma ANG II (Con: 24  5
pg/ml; Salt: 25  6 pg/ml), and plasma aldosterone (Con:
202  27 pg/ml; Salt: 199  32 pg/ml). For one subject, the
values of the 24-h renal sodium excretion prior to the
experiments were high on several occasions, up to 98
mmol/24 h; all data for this subject were excluded from the
data analysis.
Verification of the Effect of Metoprolol
Intravenous isoprenaline infusion (4 g/min) increased PRC
from 37  6 mIU/ml to 71  19 mIU/ml (P  0.01). During
administration of metoprolol [injection of 0.3 mg/(kg body wt)
plus iv infusion of 1 g kg1 min1], the same dose of
isoprenaline did not change PRC at all (35  5 to 28  5
mIU/ml). Therefore, the present protocol of metoprolol admin-
istration completely blocked the isoprenaline-mediated stimu-
lation of renin secretion.
Systemic Hemodynamics
MAP was measured every 15 min and remained stable
during the time-control series (Con: 89 mmHg and MetCon:
76 mmHg). The 1-adrenergic blockade reduced the control
values of MAP (MetCon: 77  2 and MetSalt: 76  1 mmHg
compared with Con: 90  2 and Salt: 84  3 mmHg) (Fig. 2).
Averaging the preintervention data, metoprolol decreased
MAP by 9.5 1.9 mmHg. Saline loading did not change MAP
(Salt: 84  3 to 83  2 mmHg; MetSalt: 76  1 to 75  2
mmHg, respectively). Notably, there were no trends at all
toward increases in MAP.
Heart rate was constant during the time-control series (Con);
metoprolol initially reduced heart rate (11  2 beats/min, P 
0.001), followed by a further 9% decrease over time. The
saline load generated a 5–6 beats/min (9%) decrease in heart
rate (Salt), but during metoprolol (MetSalt) heart rate remained
unchanged at 53 beats/min (Fig. 2).
CO was unchanged during the time-control series (Con) with
a first hour mean value of 7.2  0.5 l/min, but decreased
slightly in the three other series. Metoprolol per se decreased
CO by an average of 16% (Student’s t-test, P  0.01, Fig. 2),
from this reduced level, a small, but significant, decrease
occurred in the metoprolol control series (MetCon: 6.4  0.4
to 5.7  0.5 l/min, 
 	 11%). CO also decreased during the
two series with saline loading (Salt: 7.5  0.5 l/min to 6.7 
0.4 l/min and MetSalt: 6.1 0.4 l/min to 5.6 0.4 l/min) (Fig.
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2). However, these changes are similar to the mentioned 11%
decrease over time observed in CO during the time-control
series (MetCon). Therefore, the saline loading did not elicit
specific changes in CO.
Significant changes in systemic vascular resistance were not
observed, except during the saline-loading series (Salt), where
a marginal, significant increase occurred, generated mainly by
unusually low control values in two subjects.
Changes in CVP were absent in both time-control series
(Con and MetCon). CVP increased with saline loading (Salt
series, 
 	 1.9  0.6 mmHg, P  0.005; MetSalt series, 
 	
2.0  1.0 mmHg, P  0.05, Fig. 3).
Plasma Electrolytes and Osmolality
Plasma osmolality and plasma sodium concentration were
very stable in all series (Table 1). Plasma potassium concen-
tration decreased slightly in experiments without metoprolol
but was constant in the two series with metoprolol administra-
tion (Table 1).
Plasma Hormone Concentrations
Metoprolol treatment decreased PRC and ANG II by 30–
40% (Fig. 4). The decrease in plasma aldosterone was less
consistent. During saline infusion, PRC decreased markedly
from 59  13 to 34  6 mIU/l (by 43%). After metoprolol
pretreatment, the saline loading inhibited PRC to a similar, if
not larger, extent (by 57%). Similarly, the saline loading
decreased plasma ANG II equally with and without metoprolol
(by 59 and 53%, respectively). Likewise, plasma aldosterone
decreased with or without metoprolol (215  34 to 86  18
pg/ml and 143  29 to 86  9 pg/ml, Fig. 4). Taken together
the data clearly show that the 1-adrenergic blockade de-
creased the control values of the PRC and ANG II, but did not
affect the acute suppression of RAAS elicited by the saline
loading.
Plasma AVP concentrations did not change in either control
series, but decreased appreciably during saline infusion with-
out (3.0  0.4 to 1.8  0.1 pg/ml) and with metoprolol (3.0 
1.1 to 2.1  0.3 pg/ml, Table 3). Therefore, the present
protocol, which generated a marginal increase in central ve-
nous pressure at constant plasma osmolality and sodium con-
centration, nevertheless reduced vasopressin secretion.
Plasma ANP remained constant during the Con series (24  2
pg/ml to 22 2 pg/ml). There was no change due to or during the
1-adrenergic blockade (average 23 pg/ml). ANP did not
change significantly during saline loading with or without meto-
prolol (Salt: 24 3 to 24 3 pg/ml; MetSalt: 31 5 to 30 5
pg/ml, Table 3). The control values of the different series of
investigations were not significantly different.
Fig. 3. Acute effects of saline infusion on central venous pressure (
CVP).
Saline was infused from t 	 60–300 min, and results are deviations from
control values. Data shown are time control (Con, gray), metoprolol time
control (MetCon, white), saline loading (Salt, black), and saline loading during
metoprolol (MetSalt, striped). Control values were 4.0  0.7, 6.2  0.6, 5.7 
0.8, and 6.9  0.9 mmHg, respectively. *Significant difference zero by
ANOVA and Newman-Keuls test. Values are means  SE, n 	 7.
Fig. 2. Acute effects of saline infusion on mean arterial blood pressure
(MABP), cardiac output (CO), and heart rate (HR). Data shown are time
control (dashed line), metoprolol time control (dotted line), saline loading
(squares), and saline loading during metoprolol (circles). *Significant differ-
ence from preinfusion value by ANOVA and Newman-Keuls test. Significant
deviations did not occur in the two time-control series. Values are means 
SE, n 	 7.
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Renal Variables and Excretory Patterns
Neither the 1-adrenoceptor blockade nor the saline loading
elicited any significant changes in GFR (Fig. 5). During time-
control experiments, GFR was stable at 105 ml/min and
103 ml/min, in the Con and MetCon experiments, respec-
tively.
Urine flows were stable during control experiments at 4.8
ml/min and4.9 ml/min. Saline loading caused a trend toward
an increase in urine flow (Salt: 4.6  1.2 to 7.0  0.6 ml/min,
Table 2). In both saline infusion series (Salt and MetSalt), peak
urine flows (6.9 and 7 ml/min) were different from the corre-
sponding values in the appropriate control series. Urine osmo-
lality decreased considerably in intervention series (Salt:
292  71 to 157  17 mOsm/kg and MetSalt: 207  33 to
128  12 mOsm/kg), but not to values significantly different
from the respective control experiments (Con and MetCon,
Table 2).
The control values of the rate of excretion of sodium were
very similar in the different series and remained constant in the
absence of intervention (Fig. 5). In both saline-loading series,
sodium excretion increased gradually with the infusion (Fig.
5). The statistically indistinguishable increases continued into
the recovery period reaching excretion rates of 55  13
mol/min and 71  14 mol/min. Saline loading augmented
fractional sodium excretion gradually in a pattern similar to
absolute renal sodium excretion, as GFR remained unchanged
(Salt: 0.09  0.02 to 0.36  0.08% and MetSalt: 0.10  0.01
to 0.43  0.07%).
The measured changes in the CVP were small. In one of the
seven subjects, data from the control period are not available
due to a technical error. For the six other subjects, it was
possible to generate lines of regression with respect to CVP
and rate of sodium excretion. The mean slope indicates an
increase of 7 mol/min in sodium excretion for each millime-
ter of mercury change in CVP.
DISCUSSION
We tested the hypothesis that 1-mediated effects of norepi-
nephrine participate in salt-mediated RAAS suppression and
RAAS-mediated natriuresis, i.e., that the inhibition of renin
secretion and the associated natriuresis occurring during acute
saline loading under constant blood pressure, and GFR is
reduced by 1-adrenoceptor blockade. The major findings were
that 1) metoprolol significantly decreased the control values of
PRC and ANG II (30–40%); 2) saline loading decreased PRC,
plasma ANG II, and plasma aldosterone by 50–60%; and
3) this deactivation of the renin system was unimpeded by
metoprolol administration. Therefore, the results are not com-
patible with the hypothesis. The overall result is that the acute
RAAS deactivation and the RAAS-mediated natriuretic re-
sponses to modest, slow salt loading are independent of
changes in blood pressure, GFR, and 1-receptor-mediated
nerve activity.
The efficacy of the metoprolol treatment was tested in separate
experiments, which showed that the present metoprolol adminis-
tration completely abolished isoprenaline-mediated renin secre-
tion. Therefore, there is little doubt that the changes in RAAS
activity measured during metoprolol administration were not me-
diated via 1-receptors.
In recent dog experiments (7a), extracellular volume and
sodium concentration were increased simultaneously as small
doses of hypertonic saline were applied, and the deactivation of
the RAAS could be due to both volume and concentration
changes. In the present investigation, extracellular volume was
increased at constant plasma sodium concentration. The
present deactivation of the RAAS, therefore, cannot be due to
changes in sodium concentration or osmolality as both were
very stable.
The present results may be influenced by several details of
the present protocol. First, the subjects were investigated in the
reclined, but sitting, position (angle of back-support 50–60
degrees). Previous investigations in this laboratory have shown
Table 1. Effects of saline infusion on plasma parameters with and without metoprolol
Time, min 5
Preinfusion Sodium Loading Postinfusion
55 115 175 235 295 355
Plasma Osmolality, mOsmol/kg
Con 2841 2841 2885 2864 2853 2852 2831
MetCon 2861 2841 2831 2841 2841 2841 2832
Salt 2851 2841 2841 2851 2851 2841 2851
MetSalt 2851 2841 2873 2841 2851 2861 2841
Plasma Sodium, mmol/l
Con 138.60.6 137.70.6 137.60.6 137.60.6 137.80.6 138.30.5 138.10.6
MetCon 138.31.0 137.71.0 137.91.0 137.70.9 137.41.0 138.01.1 138.40.9
Salt 138.20.4 137.90.6 137.40.7 138.00.5 138.00.6 138.80.5 138.80.7
MetSalt 139.00.7 138.81.0 140.91.8 139.11.1 138.80.8 139.50.9 139.21.2
Plasma Potassium, mmol/l
Con 4.30.1 4.20.1 4.10.1 4.00.1* 4.00.1* 3.80.1* 3.70.1*
MetCon 4.20.1 4.20.1 4.20.1 4.30.1 4.30.1 4.10.1 4.10.2
Salt 4.20.1 4.20.1 4.10.1 4.10.1 3.90.1* 4.00.1* 4.00.1*
MetSalt 4.10.1 3.60.6 4.20.1 4.20.1 4.10.1 4.00.1 4.10.1
Values are means  SE; n 	 7. Con, time-control series; MetCon, time-control with metoprolol; Salt, sodium-loading series; MetSalt, sodium loading with
metoprolol. *Significant difference from preinfusion value by ANOVA and Newman-Keuls test.
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that in the supine position, normal subjects may show a
threefold increase in sodium excretion over a few hours with-
out any intervention (4). Therefore, any change in sodium
excretion in supine humans should be evaluated relative to the
results of stringent time-control experiments. In the present
experiments, all variables measured (except plasma potassium)
were shown to be stable during the time-control series. Another
advantage of the sitting position is that the orthostatic alter-
ations associated with micturition are minimized. The present
male subjects emptied their bladder while briefly standing up.
The hemodynamic changes (e.g., baroreceptor deactivation)
associated with standing up from sitting are much smaller than
with standing up from the supine position. Second, the saline
was infused at a very low rate for an extended period in time
to minimize the rate of change, e.g., in hemodynamic variables.
This intention was fulfilled as blood pressure and heart rate
remained very stable through the perturbation. Third, the in-
fusate was physiological saline, slightly diluted by water to
avoid differences between the concentrations of sodium in infusate
and plasma. In a previous, similar study of slow sodium loading
(27) a higher dose rate (20 mol NaCl kg1 min1) was given
as normal saline (154 mmol/l) with the consequence that
plasma sodium concentration increased marginally, but signif-
icantly. In the present study, normal saline was diluted about
Fig. 5. Acute effects of saline infusion on glomerular filtration rate (GFR) and
sodium and potassium excretion. Time control (dashed line). Data shown are
metoprolol time control (dotted line), saline loading (squares), and saline
loading during metoprolol (circles). *Significant difference from preinfusion
value by ANOVA and Newman-Keuls test. Significant deviations did not
occur in the two time-control series. Values are means  SE, n 	 7.
Fig. 4. Acute effects of saline infusion on plasma renin concentration (PRC),
plasma ANG II (pANGII), and plasma aldosterone (pAldo). Data shown are
time control (dashed line), metoprolol time control (dotted line), saline loading
(squares), and saline loading during metoprolol (circles). *Significant differ-
ence from preinfusion value by ANOVA and Newman-Keuls test. Significant
deviations did not occur in the two time-control series. Values are means 
SE, n 	 7.
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12%, lowering the sodium concentration to 135 mmol/l, and
plasma sodium concentrations were very stable during the
interventions at 138–139 mmol/l. Finally, the inhibition of the
renin system occurred from elevated levels generated by a
low-sodium diet. It is evident that this standardized, elevated
starting level provides a favorable basis for quantitative com-
parisons of deactivation of the RAAS.
Metoprolol Infusion
The acute hemodynamic and renal effects of metoprolol
were expected (average decrease in blood pressure of11%
3% concomitant with a similar change in heart rate without
significant alterations in peripheral resistance). The overall
metoprolol effect on GFR, urine flow, and renal excretory
pattern of sodium and potassium was negligible. Similar
changes have been described by others (34, 35). As discussed
in the preceding paper (7a), the effects of systemic 1-adren-
ergic blockade in the intact animal may be complex, particu-
larly if results of renal nerve recordings in anesthetized rabbits
before and after administration of the atenolol and propranolol
(12, 13) are interpreted to indicate that 1-adrenergic antago-
nists decrease renal nerve activity. If so, metoprolol, in addi-
tion to the decrease in renin secretion, may have changed the
general nervous setting, in which the kidney responded to the
salt loading. However, as indicated by the similarity between
the control measurements obtained prior to salt loading with
and without administration of metoprolol, any inhibitory effect
of metoprolol on renal sympathetic tone has little, if any, effect
on renal function.
Renin Secretion
It is well known that renin secretion is inhibited by an
increase in renal perfusion pressure via intrarenal baroreceptor
activity by a decrease in RSNA and by enhanced delivery of
NaCl to the MD region (25, 30, 32). Based on previous studies
in humans (4, 6, 27) and dogs (28), including the preceding
paper (7a), the present protocol was designed to investigate the
effect of 1-adrenoceptor blockade under conditions where
MAP and GFR were constant. Consequently, the inhibition of
the renin system under the present conditions was assumed
sensitive to such blockade. However, our data clearly show that
elimination of the 1-mediated effects do not affect the acute,
regulatory deactivation of the RAAS in response to a modest
sodium load. Under the present conditions, it is not possible to
assess tubular fluid solute concentrations at the MD. Alter-
ations of GFR are only one of the determinants of the amount
of NaCl delivered to MD. The absence of changes in GFR does
not necessarily indicate that the MD NaCl concentration re-
mained stable, it only demonstrates that one contributor to
deviations in MD NaCl concentration was inoperative. It seems
likely, that changes in proximal sodium reabsorption occurred
and modified the distal load to MD, and thereby influenced
renin secretion. The renal clearance of lithium ions can be used
for calculation of proximal sodium reabsorption (31). How-
ever, this measure is valid only under the assumption that the
rate of reabsorption of lithium in nephron segments distal to the
pars recta of the proximal tubule is negligible. The assumption
Table 2. Effects of saline infusion on renal parameters with and without metoprolol
Time, min
Preinfusion Sodium Loading Postinfusion
0-59 60-119 120-179 180-239 240-299 300-359
Urine Flow, ml/min
Con 5.00.6 5.00.4 5.50.5 4.50.6 4.90.3 3.80.6
MetCon 4.30.9 4.70.7 6.20.6 4.00.7 5.50.4 4.50.7
Salt 4.61.2 6.20.9 6.90.6 7.00.6† 6.10.8 5.50.8
MetSalt 5.10.7 6.30.8 6.50.5 6.90.9† 6.51.0 6.60.8
Urine Osmolality, mOsm/kg
Con 21135 16126 14131 14313 12412 18334
MetCon 350111 21041 13315* 18630 13315* 17541
Salt 29271 16224* 12713* 12611* 13014* 15717*
MetSalt 20733 15633 13116 12120 11610 12812
Free-Water Clearance, ml/min
Con 1.60.7 2.40.5 2.90.6 2.50.5 2.90.4 1.70.7
MetCon 0.71.0 1.80.7 3.51.3 1.80.6 3.00.5 2.30.7
Salt 1.31.0 3.10.7* 4.00.5* 4.00.5* 3.50.7* 2.70.7*
MetSalt 1.80.7 3.30.7 3.70.6 4.30.8 4.00.8 3.80.6
Values are means  SE; n 	 7. *Significant difference from preinfusion value by ANOVA and Newman-Keuls test. †Significant difference from
corresponding Con value by paired t-test.
Table 3. Effects of saline infusion on plasma hormones with
and without metoprolol
Time, min
Preinfusion Sodium Loading Postinfusion
55 235 355
Plasma AVP, pg/ml
Con 2.90.6 2.80.6 2.60.5
MetCon 3.60.8 2.70.9 3.11.0
Salt 3.00.4 2.00.2* 1.80.1*
MetSalt 3.00.6 2.30.3* 2.10.3*
Plasma ANP, pg/ml
Con 242 192* 222
MetCon 242 213 232
Salt 243 254 243
MetSalt 315 294 305
Values are means  SE; n 	 7. AVP, arginine vasopressin. *Significant
difference from preinfusion value by ANOVA and Newman-Keuls test.
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is reasonable only when distal sodium-to-lithium concentration
ratio is high, but this is not necessarily the case during expo-
sure to a low-salt diet. For this reason, proximal sodium
reabsorption was not measured in the present investigation, and
it cannot be excluded that proximal reabsorption was de-
creased, that MD solute concentrations increased during our
interventions and that MD-mediated mechanisms, therefore,
played a major role in the control of renin secretion and of
sodium excretion under the present conditions. However, if this
were to be the case, the primary homeostatic control of the rate
of excretion of sodium, i.e., the regulation of total body
sodium, is mediated via changes in proximal reabsorption. This
may seem less likely or at least at odds with current concepts
of relative constancy of distal tubular solute load and final
regulation of renal sodium excretion being exerted by adjust-
ments in distal tubular reabsorption of sodium (11, 29).
MAP and GFR remained stable during our saline loading,
and it is unlikely that increased renal afferent arteriolar pres-
sure increased and decreased renin secretion under the present
conditions. Previous findings in our laboratory indicate that, at
modest perturbations, the regulation of renin is not primarily
dependent of MAP (27). Earlier studies have shown that
changes in arterial pressure, i.e., pressure natriuresis, is a
powerful controller of sodium excretion (14, 17). Our data do
not address the role of pressure natriuresis, but in the light of
the present results, it seems valid to assume that MAP is not a
critical factor in the control of renin secretion and sodium
secretion under physiological conditions in humans.
With the present protocol, receptors were blocked through-
out the body, and in the kidney, this blockade may eliminate
the effect of locally released as well as circulating norepineph-
rine. More specifically, the separate experiments showed that
the 1-receptors involved in renin secretion were effectively
blocked. However, the deactivation of the RAAS and the
natriuresis in response to saline loading were unimpeded.
Although incompatible with an important role of 1-receptor-
mediated control of renin secretion, our data do not exclude
that other components of RSNA are involved. Micropuncture
studies may indicate possible mechanisms; the work of Wong
et al. (33) provided direct evidence that the active NaCl
reabsorption in the early proximal tubule is selectively blocked
by prazosin, a selective 1-adrenoceptor antagonist. Conse-
quently, our results may indicate either that an unknown
regulator of renin secretion is essential or that known compo-
nents of the regulation of renin secretion are active in an
unexpected way, e.g., that an 1-receptor-mediated decrease in
proximal reabsorption is the primary regulator of sodium
balance via changes in renin secretion. Homeostatic renin
secretion could be applied to describe the unknown regulation
of renin secretion occurring in the absence of changes in MAP,
GFR, and 1-mediated effects of norepinephrine. The most
likely candidate for a sensor mechanism involved in the ho-
meostatic renin secretion seems to be the low-pressure (car-
diovascular) receptors supposedly triggered by the 2-mmHg
increase in CVP. The finding, that plasma vasopressin de-
creased at very stable values of plasma sodium and osmolality,
supports the assumption that volume receptor signals were
indeed augmented by the present small change in CVP. The
receptors could be atrial-type B-receptors (16), and these may
be located at the left side of the heart (1), as isolated changes
on the right side of the heart at a magnitude much larger than
the present increases appear ineffective with respect to renin
secretion (3). The efferent pathway is not known. It is reason-
able to assume that all 1-receptors were blocked during the
present experiments. If so, the efferent mechanism linking the
central nervous system to deactivation of the RAAS activity
could be either a decrease in RSNA not operating via 1-
adrenoceptors, e.g., -receptors, causing a decrease in proxi-
mal reabsorption eventually leading to a decrease in renin
secretion (see above) or an increase in a humoral substance
directly inhibiting the secretion from the granular cells. On one
side, it is well known that a decrease in RSNA elicited e.g., by
the saline loading, is able to decrease NaCl reabsorption by a
direct action on both proximal tubule and the loop-of-Henle
(10). On the other side, circulating renin inhibitor(s) may be
involved. In this context, the recent results obtained by Lohm-
eier et al. (23) in conscious dogs are interesting; they found that
renin secretion from denervated kidneys remained unchanged
during hypotension due to baroreceptor activation, seemingly
indicating that at least one major, nonnervous controller of
renin secretion and RAAS-dependent blood pressure remains
unknown. The present experiments were not designed to ad-
dress this issue.
Natriuretic Mechanisms
The regulation of the renal sodium excretion is complex, and
the natriuretic response to volume loading is considered, at
least under experimental conditions, to be mediated by a
combination of physical, neural, and endocrine factors. In our
experiments, the decrease in RAAS activity seems a suitable
explanation of the increase in sodium excretion. The unsolved
puzzle is the mechanism by which renin secretion is deacti-
vated. Recent studies in conscious rats may provide sugges-
tions in this regard. Renal denervation did not affect the renin
inhibitory or natriuretic responses to a sodium load (50
mol kg1 min1), which elicited a slight increase (5–8
mmHg) in MAP (21), compatible with the notion that RSNA
plays only a minor role when MAP increases measurably.
However, preliminary results have shown 1) that a lower
infusion rate (20 mol kg1 min1), which did not change
MAP, nevertheless reduced RSNA (measured by implanted
electrodes) and 2) that the natriuresis induced by this sodium
load was eliminated by renal denervation (7). These results in
rats seem to indicate that non-1-components of RSNA are
involved in homeostatic renin secretion. However, other mod-
ulators of proximal reabsorption and/or renin secretion may
well be important. There is no paucity of candidates (e.g.,
-adrenergic and dopaminergic control of proximal reabsorp-
tion, adenosine concentration changes in the renal interstitium
driven by proximal reabsorption, prostaglandin, and nitric
oxide-mediated control of renin secretion). The challenge is to
document a homeostatic function, i.e., a link between minor
changes in total body sodium and the operation of a signaling
pathway operating on renin secretion without changes in blood
pressure, GFR, or 1-adrenoceptor sensitive mechanisms. Con-
vincing results seem to require carefully designed investiga-
tions of human subjects or conscious animals.
It has been suggested that salt loads administered via the
gastrointestinal tract elicit specific signals important to sodium
homeostasis in analogy to the incretin effect of glucose me-
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tabolism. We investigated this notion a few years ago by
administering a sodium load equivalent to 10% of that con-
tained in the individually measured extracellular volume (5).
The load was given either as isotonic or as hypertonic saline
intravenously or by gastric tube. The results were not compat-
ible with an incretin-like effect (5). On this basis, the present
conclusions may seem representative for the response of nor-
mal man to acute salt and fluid excess regardless of mode of
administration.
Summary
Our results indicate that 1-adrenergic nerve activity does
not have an essential role in the acute PRC response to sodium
loading occurring in normal man in the absence of changes
in blood pressure and GFR. Consequently, they suggest that
the homeostatic, e.g., meal-related, control of sodium ex-
cretion occurs independently of the classical regulators of
renin secretion. It cannot be excluded that MD is of major
importance, but if so, the mechanisms seem to involve
changes in proximal tubular sodium reabsorption not nor-
mally assumed to play a major role in the homeostatic
regulation of sodium excretion.
Perspectives
The mechanisms of suppression of the renin system are
pivotal to the regulation of sodium balance, extracellular fluid
volume, and arterial blood pressure. The present results indi-
cate that a comprehensive analysis of the physiological control
of renin secretion must include a fourth factor in addition
to renal arterial pressure, 1-mediated effects of norepi-
nephrine, and GFR-related MD electrolyte exposure or an
unrecognized homeostatic mode of operation of one or more
of these classical regulators, notably renal nerve activity
mediated via -receptors. This factor or mode of operation
is a primary defense against increases in total body sodium
and, therefore, of major interest to the analysis of normal
blood pressure regulation and of the pathophysiology of
major diseases including abnormal fluid volume and pres-
sure control.
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